Metronomics: Intrinsic Anakoinosis Modulator?

被引:10
作者
Andre, Nicolas [1 ]
Carre, Manon [2 ]
Pasquier, Eddy [2 ]
机构
[1] Hop Enfants La Timone, AP HM, Serv Hematol & Oncol Pediat, Marseille, France
[2] Aix Marseille Univ, CNRS, INSERM, Inst Paoli Calmettes,CRCM, Marseille, France
关键词
anakoinosis; metronomic chemotherapy; drug repositioning; biology of system; chaos; CHEMOTHERAPY; CANCER; THERAPY; SYSTEMS; FUTURE; CHAOS;
D O I
10.3389/fphar.2018.00689
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 19 条
[1]   Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all? [J].
Andre, Nicolas ;
Tsai, Kelvin ;
Carre, Manon ;
Pasquier, Eddy .
TRENDS IN CANCER, 2017, 3 (05) :319-325
[2]   Metronomics: towards personalized chemotherapy? [J].
Andre, Nicolas ;
Carre, Manon ;
Pasquier, Eddy .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (07) :413-431
[3]   Has the time come for metronomics in low-income and middle-income countries? [J].
Andre, Nicolas ;
Banavali, Shripad ;
Snihur, Yuliya ;
Pasquier, Eddy .
LANCET ONCOLOGY, 2013, 14 (06) :E239-E248
[4]   Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report [J].
Berland, Mahe ;
Padovani, Laetitia ;
Rome, Angelique ;
Pech-Gourg, Gregoire ;
Figarella-Branger, Dominique ;
Andre, Nicolas .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[5]   Drug repurposing in oncology-patient and health systems opportunities [J].
Bertolini, Francesco ;
Sukhatme, Vikas P. ;
Bouche, Gauthier .
NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (12) :732-U100
[6]   Self-organization, complexity and chaos: The new biology for medicine [J].
Coffey, DS .
NATURE MEDICINE, 1998, 4 (08) :882-885
[7]   Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia [J].
Hart, Christina ;
Vogelhuber, Martin ;
Wolff, Daniel ;
Klobuch, Sebastian ;
Ghibelli, Lina ;
Foell, Juergen ;
Corbacioglu, Selim ;
Rehe, Klaus ;
Haegeman, Guy ;
Thomas, Simone ;
Herr, Wolfgang ;
Reichle, Albrecht .
CANCER MICROENVIRONMENT, 2015, 8 (02) :75-92
[8]   Lessons from phase III clinical trials on anti-VEGF therapy for cancer [J].
Jain, RK ;
Duda, DG ;
Clark, JW ;
Loeffler, JS .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01) :24-40
[9]  
Janecka Ivo P, 2007, Int J Med Sci, V4, P164
[10]   The anti-angiogenic basis of metronomic chemotherapy [J].
Kerbel, RS ;
Kamen, BA .
NATURE REVIEWS CANCER, 2004, 4 (06) :423-436